In focus · trending topic

interstitial lung disease

2 stories · following the connections

aTyr Pharma Doses First Subjects in Phase 1 Trial of iMod.Fc (ATYR1923)

By Nasdaq OMXNov 27, 2017, 1:01 PM UTC

aTyr Pharma Announces Third Quarter 2017 Operating Results and Provides Corporate Update

By Nasdaq OMXNov 14, 2017, 9:06 PM UTC